Innovative Clinical Research Solutions
- Since 1991 -
Full-Service, Dedicated, Data Driven – from “Thought to Finish”, Every Trial, Every Time.
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients Preliminary results from phase 1 clinical trial of WP1220 for treatment of cutaneous T-cell lymphoma (“CTCL”); supports phase 2 study. “For years, p-STAT3 (the activated form of STAT3) has been considered an ‘undruggable’
Set a Virtual Meeting With Us!
- Contact Ronny Schnel (310-619-6691 PT USA) for a Zoom Teleconference
- DIA 2020 Annual – June 14-18, Washington, DC
- International Congress on Advances in Clinical Research and Trials – June 15-16, Vancouver, CAN
- Outsourcing in Clinical Trials Medical Device USA – June 24-25, Minneapolis, MN
- iPharma Global Pharma Conference – July 5-7, London, UK
- Clinical Ops in Oncology Trials – July 15-16, Boston, MA
- International Lung Cancer Congress – July 23-25, Huntington Beach, CA